Abstract
Objective: The aim of this study was to screen for compounds with relatively high inhibitory activity on acetylcholinesterase.
Methods: Classification models for acetylcholinesterase inhibitors based on KNN (1-nearest neighbors), and a quantitative prediction model based on support vector machine regression were used. The interaction of the compounds and receptors was analyzed using the molecular simulation method.
Results: The radial basis kernel function was selected as the kernel function for support vector machine regression, and a total of 19 descriptors were selected to construct the quantitative prediction model.
Keywords: Alzheimer's disease, acetylcholinesterase inhibitor, non-acetylcholinesterase inhibitor, QSAR model, molecular simulation, SVM.
Graphical Abstract
Current Bioinformatics
Title:Virtual Screening of Acetylcholinesterase Inhibitors Based on Machine Learning Combined with Molecule Docking Methods
Volume: 16 Issue: 7
Author(s): Jinyu Yan, Weiguang Huang, Chi Zhang*, Haizhong Huo*Fuxue Chen*
Affiliation:
- Huaxia Eye Hospital of Foshan, Huaxia Eye Hospital Group, Foshan, Guangdong 528000,China
- Department of General Surgery, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai,China
- School of Life Sciences, Shanghai University, Shanghai,China
Keywords: Alzheimer's disease, acetylcholinesterase inhibitor, non-acetylcholinesterase inhibitor, QSAR model, molecular simulation, SVM.
Abstract:
Objective: The aim of this study was to screen for compounds with relatively high inhibitory activity on acetylcholinesterase.
Methods: Classification models for acetylcholinesterase inhibitors based on KNN (1-nearest neighbors), and a quantitative prediction model based on support vector machine regression were used. The interaction of the compounds and receptors was analyzed using the molecular simulation method.
Results: The radial basis kernel function was selected as the kernel function for support vector machine regression, and a total of 19 descriptors were selected to construct the quantitative prediction model.
Export Options
About this article
Cite this article as:
Yan Jinyu, Huang Weiguang , Zhang Chi *, Huo Haizhong *, Chen Fuxue *, Virtual Screening of Acetylcholinesterase Inhibitors Based on Machine Learning Combined with Molecule Docking Methods, Current Bioinformatics 2021; 16 (7) . https://dx.doi.org/10.2174/1574893615999200719234045
DOI https://dx.doi.org/10.2174/1574893615999200719234045 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Discovery of Small Molecule c-Met Inhibitors: Evolution and Profiles of Clinical Candidates
Anti-Cancer Agents in Medicinal Chemistry TGF-beta Signaling in Cancer Treatment
Current Pharmaceutical Design Adhesion Mechanisms of the Lyme Disease Spirochete, Borrelia burgdorferi
Current Drug Targets - Infectious Disorders dUTPase in Human Neoplastic Cells as a Potential Target for Therapeutic Intervention
Current Protein & Peptide Science The Development of Future Research Strategies from Reviewing Antiemetic Trials for Chemotherapy Induced Emesis
Reviews on Recent Clinical Trials Review of Recent Clinical Developments and Patents for the Treatment of Autoimmune and Inflammatory Diseases by Mesenchymal Stromal Cells
Recent Patents on Regenerative Medicine Aurora A and B Kinases - Targets of Novel Anticancer Drugs
Recent Patents on Anti-Cancer Drug Discovery Arsenic Trioxide Targets miR-125b in Glioma Cells
Current Pharmaceutical Design Liposomes as Versatile Platform for Cancer Theranostics: Therapy, Bio-imaging, and Toxicological Aspects
Current Pharmaceutical Design The Urokinase Receptor as a Potential Target in Cancer Therapy
Current Pharmaceutical Design Considering Autotaxin Inhibitors in Terms of 2D-QSAR and 3D-Mapping- Review and Evaluation
Current Medicinal Chemistry Thirty Years of Polyamine-Related Approaches to Cancer Therapy. Retrospect and Prospect. Part 2. Structural Analogues and Derivatives
Current Drug Targets Signal Transduction Therapy Targeting Apoptosis Pathways in Cancers
Current Signal Transduction Therapy Evaluation of Three Synthetic Membranes as Limiting Barrier for in vitro Drug Release Studies from Hydrogels Containing Polymeric Nanocapsules
Current Nanoscience Targeting the Phosphatidylinositol 3-Kinase/AKT Pathway for the Treatment of Multiple Myeloma
Current Medicinal Chemistry Elastin-Like Recombinamers As Smart Drug Delivery Systems
Current Drug Targets Inhibitors of the TGF-β Superfamily and their Clinical Applications
Mini-Reviews in Medicinal Chemistry Immunotherapeutic Options for Pediatric Malignancies
Current Immunology Reviews (Discontinued) Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Current Status of Epigenetics and Anticancer Drug Discovery
Anti-Cancer Agents in Medicinal Chemistry